Effects of the Histone Deacetylase Inhibitor ITF2357 in Autoinflammatory Syndromes

We explored the effects of the oral histone deacetylase (HDAC) inhibitor ITF2357 in patients with autoinflammatory syndrome. In this prospective open-label pilot study, eight patients were enrolled; one patient with tumor necrosis factor receptor–associated periodic syndrome (TRAPS), three patients...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Bodar, Evelien J, Simon, Anna, van der Meer, Jos WM
Format: Artigo
Sprache:Inglês
Veröffentlicht: ScholarOne 2011
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3105134/
https://ncbi.nlm.nih.gov/pubmed/21274502
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2119/molmed.2011.00039
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge